Increased Hepatic INSIG-SCAP-SREBP Expression is Associated with Cholesterol Metabolism Disorder in Assisted Reproductive Technology-Conceived Aged Mice.

Fang Le,Hang-Ying Lou,Qi-Jing Wang,Ning Wang,Li-Ya Wang,Le-Jun Li,Xin-Yun Yang,Qi-Tao Zhan,Yi-Yun Lou,Fan Jin

DOI: https://doi.org/10.1016/j.reprotox.2018.12.003

2018-01-01

Abstract:Although most children conceived by assisted reproductive technology (ART) are healthy, there are concerns regarding the potential long-term health implications of ART. It has been reported that alterations in insulin-induced gene (INSIG), sterol regulatory element binding protein (SREBP), and SREBP cleavage-activating protein (SCAP) are involved in cardiometabolic changes. Thus, ART mouse models were established via in vitro fertilization (IVF), intracytoplasmic injection (ICSI), and in vitro oocyte maturation (IVM). A significantly higher systolic blood pressure was identified in the IVM aged female mice. In addition, abnormalities in the blood lipids and liver function were identified in the IVM- or ICSI-conceived elderly mice. Furthermore, ICSI or IVM significantly affected the hepatic expression and methylation of INSIG-SCAP-SREBP from a young to old age. Our animal data indicated that ICSI or IVM result in a higher risk of cholesterol metabolism dysfunction in older mice, which may be associated with long-term alterations of INSIG-SCAP-SREBP.